Track topics on Twitter Track topics that are important to you
Av. Brasil, 4365 - Pavilhão Rocha Lima
Rio de Janeiro - RJ
Phone: (21) 3882-9393
Chembio Diagnostics (Nasdaq:CEMI), a leader in point-of-care (“POC”) diagnostic tests for infectious diseases, today announced the signing of a long-term agreement with Bio-Manguinhos to c...
The purpose of this study is to determine occurrence of pure red cell aplasia in a group of participants with chronic renal insufficiency and with resistance criteria to epoetin alfa treat...
Measles and rubella are highly contagious acute viral diseases. As per WHO, several evidences demonstrate the benefit for providing the universal access to vaccines containing measles and ...
In July 2016, the demand for yellow fever vaccines in response to the large urban outbreaks occurring concurrently and the risk of further spread through the African continent and even to ...
TYPE / DESIGN STUDY: Clinical trial phase II / III, randomized, double-blind, national multi-center, with a total of 1,644 research participants stratified into 3 groups according to age f...
Bio-Manguinhos é o maior fornecedor de vacinas do Ministério da Saúde, além de único produtor nacional dos imunobiológicos que compõem sua linha de produtos - que abrange vacinas pediátricas t...
We have published hundreds of Bio-Manguinhos news stories on BioPortfolio along with dozens of Bio-Manguinhos Clinical Trials and PubMed Articles about Bio-Manguinhos for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Bio-Manguinhos Companies in our database. You can also find out about relevant Bio-Manguinhos Drugs and Medications on this site too.